Forget SpaceX Hype: Billionaire Stanley Druckenmiller is Loading Up on This Unknown Healthcare Stock We just covered the Top 10 Stock Picks of 10 Famous Billionaires.
Natera (NASDAQ:NTRA) ranks #7 (see Top 5 Stock Picks of 5 Famous Billionaires)
Number of Hedge Funds: 68 Top Pick Of: Stanley Druckenmiller — Duquesne Family Office Natera (NASDAQ:NTRA) is the largest holding of billionaire investor Stanley Druckenmiller. The company develops genetic and molecular diagnostic tests used in oncology, women’s health, and organ health. Its biggest growth driver is Signatera, a personalized blood test that detects traces of cancer DNA after treatment.
The test helps determine whether cancer has returned and is used for recurrence monitoring and treatment decisions. Roughly 50% of U.S. oncologists are already ordering Signatera. Other oncology products include Altera, Latitude, and Empower.